Literature DB >> 8276186

Identification of human biliary alpha 1-acid glycoprotein as a cholesterol crystallization promoter.

M Abei1, H Nuutinen, P Kawczak, J Schwarzendrube, S P Pillay, R T Holzbach.   

Abstract

BACKGROUND/AIMS: We have recently outlined the biochemical features of a human 42-kilodalton biliary glycoprotein that shows concentration-dependent cholesterol crystallization-promoting activity. The goal in this work was to establish its identity and to examine some aspects of its biochemical properties relative to its activity.
METHODS: Internal amino acid sequencing following tryptic digestion was performed. Based upon this result, immunoreactivity against the 42-kilodalton glycoprotein was examined using a relevant antibody. With the same antibody, the 42-kilodalton glycoprotein was isolated from bile and assayed for activity. Sequential enzymatic deglycosylation of successive terminal glycans of the purified glycoprotein was performed, and the effects on both reductions in molecular radius (M(r)) and on comparative promoter activities were examined.
RESULTS: Both amino acid sequence and immunochemical data identify the 42-kilodalton glycoprotein as a biliary form of alpha 1-acid glycoprotein. When purified by immunoaffinity chromatography, potent promoting activity shown was proportionately reduced by successive removal of terminal glycans that also reduced the M(r)s.
CONCLUSIONS: The 42-kilodalton cholesterol crystallization-promoting glycoprotein is now identified as a biliary form of alpha 1-acid glycoprotein. Further, some aspects of the important role of glycans in this extensively glycosylated protein have been explored.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8276186     DOI: 10.1016/s0016-5085(94)95643-x

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  8 in total

1.  Quantitative assessment of comparative potencies of cholesterol-crystal-promoting factors: relation to mechanistic characterization.

Authors:  T Nishioka; S Tazuma; G Yamashita; G Kajiyama
Journal:  Biochem J       Date:  1998-06-01       Impact factor: 3.857

2.  Interaction of cholesterol-crystallization-promoting proteins with vesicles.

Authors:  M A de Bruijn; B G Goldhoorn; A I Zijlstra; G N Tytgat; A K Groen
Journal:  Biochem J       Date:  1995-01-01       Impact factor: 3.857

3.  Partial replacement of bile salts causes marked changes of cholesterol crystallization in supersaturated model bile systems.

Authors:  T Nishioka; S Tazuma; G Yamashita; G Kajiyama
Journal:  Biochem J       Date:  1999-06-01       Impact factor: 3.857

4.  Cholesterol crystal binding of biliary immunoglobulin A: visualization by fluorescence light microscopy.

Authors:  F Lammert; S Südfeld; N Busch; S Matern
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

5.  Role of phospholipase A2 in cholesterol gallstone formation is associated with biliary phospholipid species selection at the site of hepatic excretion: indirect evidence.

Authors:  Y Hattori; S Tazuma; G Yamashita; H Ochi; Y Sunami; T Nishioka; H Hyogo; S Yasumiba; T Kajihara; K Nakai; K Tsuboi; Y Asamoto; M Sakomoto; G Kajiyama
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

6.  Biliary alpha 1-acid glycoprotein concentrations in gallstone-free controls and in patients with multiple or solitary cholesterol gallstones.

Authors:  H Nuutinen; M Abei; J Schwarzendrube; S Ginanni Corradini; R M Walsh; P Kawczak; R T Holzbach
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

7.  Comparative effects on biliary concanavalin A-bound glycoproteins and calcium ion on cholesterol crystal nucleation and growth in model bile.

Authors:  K Teramen; S Tazuma; T Ohya; G Kajiyama
Journal:  J Gastroenterol       Date:  1995-08       Impact factor: 7.527

8.  Correlation between biliary alpha 1-acid glycoprotein concentration and cholesterol crystal nucleation time in gallstone disease.

Authors:  H Nuutinen; S Ginanni Corradini; D Jüngst; V Lange; M Abei; J Schwarzendrube; C Williams; R T Holzbach
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.